What are the main differences between Ambien and Belsomra in terms of morning grogginess and long term dependency risks for busy parents
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
What are the main differences between Ambien and Belsomra in terms of morning grogginess and long term dependency risks for busy parents
3 real searches · 1 real-search pass
FDA Ambien zolpidem prescribing information next morning impairment dependence withdrawal labelGoogle ↗
OBSERVED
FDA Belsomra suvorexant prescribing information next day driving dependence abuse controlled substance labelGoogle ↗
OBSERVED
AASM guideline zolpidem suvorexant insomnia evidence next day impairment comparativeGoogle ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 3 queries…
Searches and sources
ChatGPT3 real searches · gpt-6
FDA Ambien zolpidem prescribing information next morning impairment dependence withdrawal label Google ↗
FDA Belsomra suvorexant prescribing information next day driving dependence abuse controlled substance label Google ↗
AASM guideline zolpidem suvorexant insomnia evidence next day impairment comparative Google ↗
- These highlights do not include all the information needed to use AMBIEN safely and effectively. See full prescribing information for AMBIEN. AMBIEN ®(zolpidem tartrate) tablets, for oral use, C-IV Initial U.S. Approval: 1992 · dailymed.nlm.nih.gov
- DailyMed · dailymed.nlm.nih.gov
- Questions and Answers: Risk of next-morning impairment after use of insomnia drugs; FDA requires lower recommended doses for certain drugs containing zolpidem (Ambien, Ambien CR, Edluar, and Zolpimist) · fda.gov
- These highlights do not include all the information needed to use BELSOMRA safely and effectively. See full prescribing information for BELSOMRA. BELSOMRA® (suvorexant) tablets, for oral use, C-IV Initial U.S. Approval: 2014 · dailymed.nlm.nih.gov
- These highlights do not include all the information needed to use AMBIEN safely and effectively. See full prescribing information for AMBIEN. AMBIEN® (zolpidem tartrate) tablets, for oral use, C-IV Initial U.S. Approval: 1992 · dailymed.nlm.nih.gov
Queries
3 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
FDA Ambien zolpidem prescribing information next morning impairment dependence withdrawal label OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
FDA Belsomra suvorexant prescribing information next day driving dependence abuse controlled substance label OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
AASM guideline zolpidem suvorexant insomnia evidence next day impairment comparative OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |